Uncategorised - European Medical Journal

Impact of Targeted Therapies on Functional Tricuspid Regurgitation in Pulmonary Arterial Hypertension

Tricuspid regurgitation (TR) is secondary in over 90% of cases, driven by chronic pressure or volume overload of the right…

Immunotherapy Before Liver Transplant Linked to Improved Survival

Immunotherapy before liver transplantation was linked to longer survival and lower cancer recurrence in patients with hepatocellular carcinoma.

Interview: Harriet Gordon on Her Vision for the BSG and Supporting the Gastroenterology Workforce

Gastroenterology has changed hugely over the course of my career, and it’s still changing. We can now risk-stratify patients using…

Salmonella Resistance May Help Probiotics Survive Antibiotics

Resistant Salmonella may protect probiotics during antibiotic treatment, offering a potential new approach to tackling antimicrobial resistance.

Opinion: Real-World Evidence and the Future of Healthcare Regulation

The MHRA’s new strategy highlights how real-world evidence, AI-driven analysis, and clinician reporting could support better patient outcomes across healthcare. MHRA Chair, Anthony Harnden, shares his insights.

someone holding tiny test tubes

Plasma Proteomics Uncovers Biomarkers in Patients with PBC

Researchers identified blood protein markers that could differentiate primary biliary cholangitis from MASLD and healthy controls, highlighting the potential of proteomics to support earlier diagnosis and disease monitoring.

Treatment inertia in MDD

Clinical guidelines (including those issued by the APA and CANMAT) recommend treatment modification in patients with MDD who…

X-ray of a lung

Screening Detects Smaller, Slower-Growing Lung Tumours

A study of screen-detected lung cancers found that adenocarcinomas were more likely to be smaller, slower-growing, diagnosed at an earlier stage.

HPV infection

Infection-Attributable Cancer Drives 2.3 Million Cases Worldwide

Infection-attributable cancer caused 2.3 million cases globally in 2024, representing twelve percent of all diagnosed malignancies.

Ai hand touching human hand

MHRA Predicts AI to Define Healthcare in Coming Years

MHRA outlines plans for AI oversight, medicines development and safety monitoring in its strategy to 2030.